NEUROONE MEDICAL TECHNOLOGIES Corp Contracts & Agreements
107 Contracts & Agreements
- Business Finance (59 contracts)
- Business Operations (7)
- Human Resources (9)
- Intellectual Property (4)
- Mergers & Acquisitions (1)
- Real Estate (2)
- Uncategorized (25)
- Non-Employee Director Compensation Policy (Filed With SEC on December 17, 2024)
- Amended and Restated Exclusive Development and Distribution Agreement, dated October 25, 2024, by and between NeuroOne and Zimmer (Filed With SEC on October 31, 2024)
- First Amendment to Employment Agreement between the Company and David Rosa (Filed With SEC on September 13, 2024)
- First Amendment to Offer Letter between the Company and Ronald McClurg (Filed With SEC on September 13, 2024)
- First Amendment to Offer Letter between the Company and Christopher Volker (Filed With SEC on September 13, 2024)
- First Amendment to Offer Letter between the Company and Steve Mertens (Filed With SEC on September 13, 2024)
- First Amendment to Lease Agreement, dated May 20, 2024, by and between Biynah Cleveland, LLC, BIP Cleveland LLC, Edenvale Investors, LLC and the Company (Filed With SEC on August 14, 2024)
- Form of PIPE Warrant (Filed With SEC on August 7, 2024)
- Form of Debt Facility Financing Warrant (Filed With SEC on August 7, 2024)
- Form of Securities Purchase Agreement, dated August 1, 2024 (Filed With SEC on August 7, 2024)
- Loan and Security Agreement with Growth Opportunities Funding LLC, dated August 2, 2024 (Filed With SEC on August 7, 2024)
- Employment Offer Letter, dated as of November 10, 2023, by and between Christopher Volker and the Company (Filed With SEC on November 14, 2023)
- First Amendment to 2021 Inducement Plan (Filed With SEC on November 14, 2023)
- Underwriting Agreement, dated July 24, 2023, between NeuroOne Medical Technologies Corporation and The Benchmark Company, LLC (Filed With SEC on July 27, 2023)
- Capital on Demand Sales Agreement, dated December 21, 2022 between NeuroOne Medical Technologies Corporation. and JonesTrading Institutional Services LLC (Filed With SEC on December 22, 2022)
- Warrant to Purchase Common Stock dated as of August 2, 2022 issued to Zimmer, Inc (Filed With SEC on August 11, 2022)
- Amendment No. 2 to Exclusive Development and Distribution Agreement dated as of July 1, 2022 by and between the Company and Zimmer, Inc (Filed With SEC on August 11, 2022)
- Amendment No. 3 to Exclusive Development and Distribution Agreement dated as of August 2, 2022 by and between the Company and Zimmer, Inc (Filed With SEC on August 11, 2022)
- Warrant to Purchase Common Stock (Filed With SEC on August 3, 2022)
- Third Amendment to Exclusive Distribution and Development Agreement (Filed With SEC on August 3, 2022)
- Amendment to Exclusive Development and Distribution Agreement by and between the Company and Zimmer, Inc. dated January 6, 2021 (Filed With SEC on December 15, 2021)
- Underwriting Agreement, dated October 13, 2021, between NeuroOne Medical Technologies Corporation and Craig-Hallum Capital Group LLC (Filed With SEC on October 14, 2021)
- NeuroOne Medical Technologies Corporation 2021 Inducement Plan (Filed With SEC on October 4, 2021)
- Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the NeuroOne Medical Technologies Corporation 2021 Inducement Plan (Filed With SEC on October 4, 2021)
- Form of Warrant (Filed With SEC on January 15, 2021)
- Form of Purchase Agreement (Filed With SEC on January 15, 2021)
- Employment Offer Letter, dated as of January 1, 2021, by and between Ron McClurg and the Company (Filed With SEC on January 7, 2021)
- Securities Purchase Agreement (Filed With SEC on August 3, 2020)
- Exclusive Development and Distribution Agreement dated as of July 20, 2020 by and between NeuroOne and Zimmer (Filed With SEC on July 22, 2020)
- Form of Note (Filed With SEC on May 1, 2020)
- Form of Warrant (Filed With SEC on May 1, 2020)
- Form of Subscription Agreement (Filed With SEC on May 1, 2020)
- Form of Second Amendment (Filed With SEC on April 30, 2020)
- Form of Broker Warrant (Filed With SEC on January 24, 2020)
- Amended and Restated Exclusive Start-up Company License Agreement effective January 21, 2020 by and between NeuroOne Medical Technologies Corporation and Wisconsin Alumni Research... (Filed With SEC on January 24, 2020)
- Description of Securities (Filed With SEC on December 20, 2019)
- Lock-Up Agreement dated October 21, 2019, between Wade Fredrickson and the Company (Filed With SEC on December 20, 2019)
- Form of First Amendment to Convertible Promissory Note (Filed With SEC on December 11, 2019)
- Form of Note (Filed With SEC on November 7, 2019)
- Form of Warrant (Filed With SEC on November 7, 2019)
- Form of Subscription Agreement (Filed With SEC on November 7, 2019)
- Form of Securities Purchase Agreement (Filed With SEC on October 29, 2019)
- Lease Agreement dated October 7, 2019, by and among NeuroOne Medical Technologies Corporation and Biynah Cleveland, LLC, BIP Cleveland, LLC, and Edenvale Investors (Filed With SEC on October 11, 2019)
- Amendment to Exclusive Start-Up Company License Agreement by and between Wisconsin Alumni Research Foundation and the Company, dated September 18, 2019 (Filed With SEC on September 23, 2019)
- Form of Paulson Warrant (Filed With SEC on July 5, 2019)
- Form of HRA Warrant (Filed With SEC on July 5, 2019)
- Offer Letter between Steve Mertens and NeuroOne Medical Technologies Corporation, effective April 1, 2019 (Filed With SEC on May 10, 2019)
- Letter Agreement between the Company and Lifestyle Healthcare LLC, dated May 8, 2019 (Filed With SEC on May 8, 2019)
- Form of Warrant (issued in the Conversion) (Filed With SEC on March 6, 2019)
- Offer Letter between Scott Heuler and NeuroOne Medical Technologies Corporation, dated December 10, 2018 (Filed With SEC on February 11, 2019)
- Form of Warrant (Filed With SEC on January 4, 2019)
- Form of Purchase Agreement (Filed With SEC on January 4, 2019)
- Form of Registration Rights Agreement (Filed With SEC on January 4, 2019)
- First Amendment to Convertible Promissory Notes, dated as of December 31, 2018 (Filed With SEC on December 31, 2018)
- Promissory Note between the Company and Lifestyle Healthcare LLC, dated December 12, 2018 (Filed With SEC on December 18, 2018)
- Promissory Note between the Company and Lifestyle Healthcare LLC, dated November 14, 2018 (Filed With SEC on November 20, 2018)
- Promissory Note between the Company and Jainal Bhuiyan, dated November 14, 2018 (Filed With SEC on November 20, 2018)
- Description of compensatory arrangement with Thomas Bachinski (Filed With SEC on October 30, 2018)
- Amendment to Lock-up Agreement, dated as of July 17, 2018 by and between the Company and Wade Fredrickson (Filed With SEC on July 23, 2018)
- Form of Warrant (Filed With SEC on July 13, 2018)
- Form of Purchase Agreement (Filed With SEC on July 13, 2018)
- Form of Registration Rights Agreement (Filed With SEC on July 13, 2018)
- Form of Series 1 Notes Debt Conversion Agreement (Filed With SEC on July 6, 2018)
- Form of Series 2 Notes Debt Conversion Agreement (Filed With SEC on July 6, 2018)
- Promissory Note between the Company and Lifestyle Healthcare LLC, dated May 17, 2018 (Filed With SEC on May 23, 2018)
- Promissory Note between the Company and Jainal Bhuiyan, dated May 17, 2018 (Filed With SEC on May 23, 2018)
- Non-Employee Director Compensation Policy (Filed With SEC on April 16, 2018)
- Lock-up Agreement, effective as of March 1, 2018 by and between Wade Fredrickson and the Company (Filed With SEC on April 16, 2018)
- Form of Amended and Restated Note (Filed With SEC on March 16, 2018)
- Form of Replacement Warrant (Filed With SEC on March 16, 2018)
- Form of Additional Warrant (Filed With SEC on March 16, 2018)
- Form of Amended and Restated Note (Filed With SEC on December 20, 2017)
- Form of Amended and Restated Warrant (Filed With SEC on December 20, 2017)
- Form of Amended and Restated Subscription Agreement (Filed With SEC on December 20, 2017)
- First Amendment to Promissory Note by and between the Company and the Subscribers, dated as of November 30, 2017 (Filed With SEC on December 6, 2017)
- SECONDAMENDMENT TO CONVERTIBLE PROMISSORY NOTE (Filed With SEC on November 27, 2017)
- Form of Second Amendment to 2016 Warrant (Filed With SEC on November 27, 2017)
- Form of Note (Filed With SEC on October 6, 2017)
- Form of Warrant (Filed With SEC on October 6, 2017)
- Form of Subscription Agreement (Filed With SEC on October 6, 2017)
- NEUROONE MEDICAL TECHNOLOGIES CORPORATION PROMISSORY NOTE (Filed With SEC on August 23, 2017)
- NEUROONE MEDICAL TECHNOLOGIES CORPORATION CAPITAL STOCK PURCHASE WARRANT _________________ (Filed With SEC on August 23, 2017)
- SUBSCRIPTION AGREEMENT (Filed With SEC on August 23, 2017)
- EmploymentAgreement (Filed With SEC on August 7, 2017)
- Agreementand Plan of Merger and Reorganization By and among: NeuroOneMedical Technologies Corporation, a Delawarecorporation; OSOKAcquisition Company, a Delawarecorporation; and... (Filed With SEC on July 20, 2017)
- EXCLUSIVE START-UP COMPANY LICENSEAGREEMENT (Filed With SEC on July 20, 2017)
- AMENDMENT TO EXCLUSIVE START-UPCOMPANY LICENSE AGREEMENT (Filed With SEC on July 20, 2017)
- MAYO FOUNDATION FOR MEDICAL EDUCATIONAND RESEARCH AMENDED AND RESTATED LICENSE AND DEVELOPMENTAGREEMENT (Filed With SEC on July 20, 2017)
- NeuroOne,Inc. SubscriptionAgreement (Filed With SEC on July 20, 2017)
- SUBSCRIPTION AGREEMENT (Filed With SEC on July 20, 2017)
- _______________________________ NEUROONE, INC. CONVERTIBLE PROMISSORY NOTE (Filed With SEC on July 20, 2017)
- FIRST AMENDMENT TO CONVERTIBLE PROMISSORY NOTES (Filed With SEC on July 20, 2017)
- WARRANT (Filed With SEC on July 20, 2017)
- FIRST AMENDMENT TO CAPITAL STOCK PURCHASEWARRANTS (Filed With SEC on July 20, 2017)
- StockholdersAgreement of NeuroOne,Inc. (Filed With SEC on July 20, 2017)
- NEUROONE, INC. 2016Equity Incentive Plan ADOPTEDBY THE BOARD OF DIRECTORS: October 20, 2016 APPROVED BY THE STOCKHOLDERS: October 20, 2016 TERMINATION DATE: October 20, 2026 (Filed With SEC on July 20, 2017)
- NEUROONE, INC. STOCK OPTION GRANT NOTICE (2016 Equity Incentive Plan) (Filed With SEC on July 20, 2017)
- RESTRICTED STOCKPURCHASE AGREEMENT (Filed With SEC on July 20, 2017)
- NEUROONE MEDICAL TECHNOLOGIES CORPORATION STOCK OPTION GRANT NOTICE (2017 EQUITY INCENTIVE PLAN) (Filed With SEC on July 20, 2017)
- NEUROONE MEDICAL TECHNOLOGIES CORPORATION RESTRICTED STOCK UNIT GRANT NOTICE (2017 EQUITY INCENTIVE PLAN) (Filed With SEC on July 20, 2017)
- EmploymentAgreement (Filed With SEC on July 20, 2017)
- NeuroOne,Inc. 14605Woodhaven Road Minnetonka,MN 55345 December 1, 2016 (Filed With SEC on July 20, 2017)
- NeuroOne,Inc. 14605Woodhaven Road Minnetonka,MN 55345 January 9, 2017 (Filed With SEC on July 20, 2017)
- NeuroOne,Inc. 14605Woodhaven Road Minnetonka,MN 55345 December 1, 2016 (Filed With SEC on July 20, 2017)
- RESIGNATION LETTER July 20, 2017 (Filed With SEC on July 20, 2017)
- SeparationAND Release Agreement (Filed With SEC on July 20, 2017)
- Planof Conversion PLAN OF CONVERSION OF NEUROONE MEDICAL TECHNOLOGIES CORPORATION, A NEVADA CORPORATION INTO NEUROONE MEDICAL TECHNOLOGIES CORPORATION, A DELAWARE CORPORATION (Filed With SEC on June 29, 2017)
